Please provide your email address to receive an email when new articles are posted on . Phase 3 clinical trial included 134 adults with full neuroaxis MRI and no new NMOSD symptoms. At 28 weeks, 15% ...

Multiple sclerosis (MS) is a chronic neurological disease characterized by nerve damage and consequent impairments in vision, ...

Using advanced methodology, scientists have been able to reveal at the cellular level how lesions in multiple sclerosis develop. Using advanced methodology, scientists in Sweden were able to reveal at ...

Collaborating scientists at the Karolinska Institute and at Stockholm University used a technology called in situ sequencing (ISS) to help reveal at the cellular level how lesions in multiple ...

Researchers analyzed the diagnostic value of stereotactic brain biopsy in patients with leukemia presenting central ...

—In a new study, the extent of microstructural damage in patients with early relapsing-remitting multiple sclerosis (RRMS) was associated with worse disability and spinal cord atrophy at 5 years. Here ...

In a new study in mice, a team of researchers from UCLA, the Swiss Federal Institute of Technology, and Harvard University have uncovered a crucial component for restoring functional activity after ...

DUBLIN--(BUSINESS WIRE)-- Horizon Therapeutics plc (Nasdaq: HZNP) today announced the presentation of a new analysis of MRI data from the Phase 3 clinical trial of UPLIZNA showing a reduction in the ...

For nearly 50 years, a jawless fish called the lamprey has interested scientists because of its remarkable ability to recover from spinal cord injuries. A new study reveals a possible technique ...